- Markets
- Healthcare
- FREDUN
FREDUN
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
-
Share Price
-
Financials
-
Revenue mix
-
Shareholdings
-
Peers
-
Forensics
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
This data is currently unavailable for this company.
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
(In Cr.) |
---|
(In Cr.) | ||||
---|---|---|---|---|
This data is currently unavailable for this company. |
(In %) |
---|
(In Cr.) |
---|
Financial Year (In Cr.) |
---|
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Recent events
-
News
-
Corporate Actions
Fredun Pharmaceuticals's Pharma Announces International Expansion Of Freossi Division
March 18 (Reuters) - Fredun Pharmaceuticals Ltd FRED.BO:
FREDUN PHARMACEUTICALS LTD - PHARMA ANNOUNCES INTERNATIONAL EXPANSION OF FREOSSI DIVISION
FREDUN PHARMACEUTICALS LTD - PHARMA INTRODUCES 9 PREMIUM PETCARE PRODUCTS IN SRI LANKA
Source text: ID:nBSE533f4B
Further company coverage: FRED.BO
(([email protected];))
March 18 (Reuters) - Fredun Pharmaceuticals Ltd FRED.BO:
FREDUN PHARMACEUTICALS LTD - PHARMA ANNOUNCES INTERNATIONAL EXPANSION OF FREOSSI DIVISION
FREDUN PHARMACEUTICALS LTD - PHARMA INTRODUCES 9 PREMIUM PETCARE PRODUCTS IN SRI LANKA
Source text: ID:nBSE533f4B
Further company coverage: FRED.BO
(([email protected];))
Fredun Pharmaceuticals Installs Second Italian Tube Filling Machine
Feb 3 (Reuters) - Fredun Pharmaceuticals Ltd FRED.BO:
FREDUN PHARMACEUTICALS - INSTALLS SECOND ITALIAN TUBE FILLING MACHINE
FREDUN PHARMACEUTICALS - INVESTMENT BOOSTS PRODUCTION CAPACITY BY 2.9 TIMES
Source text: ID:nBSE5BqF4w
Further company coverage: FRED.BO
(([email protected];))
Feb 3 (Reuters) - Fredun Pharmaceuticals Ltd FRED.BO:
FREDUN PHARMACEUTICALS - INSTALLS SECOND ITALIAN TUBE FILLING MACHINE
FREDUN PHARMACEUTICALS - INVESTMENT BOOSTS PRODUCTION CAPACITY BY 2.9 TIMES
Source text: ID:nBSE5BqF4w
Further company coverage: FRED.BO
(([email protected];))
Fredun Pharmaceuticals Approves Issue Of Foreign Currency Convertible Bonds Worth USD 10 Mln
Oct 3 (Reuters) - Fredun Pharmaceuticals Ltd FRED.BO:
APPROVED ISSUE OF FOREIGN CURRENCY CONVERTIBLE BONDS WORTH USD 10 MILLION
MAY ISSUE FURTHER FOREIGN CURRENCY CONVERTIBLE BONDS WORTH USD 2 MILLION
Source text for Eikon: ID:nBSE7dkdxL
Further company coverage: FRED.BO
(([email protected];;))
Oct 3 (Reuters) - Fredun Pharmaceuticals Ltd FRED.BO:
APPROVED ISSUE OF FOREIGN CURRENCY CONVERTIBLE BONDS WORTH USD 10 MILLION
MAY ISSUE FURTHER FOREIGN CURRENCY CONVERTIBLE BONDS WORTH USD 2 MILLION
Source text for Eikon: ID:nBSE7dkdxL
Further company coverage: FRED.BO
(([email protected];;))
Fredun Pharmaceuticals To Consider Issue Of Foreign Currency Convertible Bonds
Sept 26 (Reuters) - Fredun Pharmaceuticals Ltd FRED.BO:
FREDUN PHARMACEUTICALS - TO CONSIDER ISSUE OF FOREIGN CURRENCY CONVERTIBLE BONDS
Source text for Eikon: ID:nBSEb7K6YQ
Further company coverage: FRED.BO
(([email protected];))
Sept 26 (Reuters) - Fredun Pharmaceuticals Ltd FRED.BO:
FREDUN PHARMACEUTICALS - TO CONSIDER ISSUE OF FOREIGN CURRENCY CONVERTIBLE BONDS
Source text for Eikon: ID:nBSEb7K6YQ
Further company coverage: FRED.BO
(([email protected];))
Fredun Pharmaceuticals Secures Orders From Sea Countries
Feb 12 (Reuters) - Fredun Pharmaceuticals Ltd FRED.BO:
SECURES ORDERS FROM SEA COUNTRIES
ORDERS WORTH 280 MILLION RUPEES
EXPANDS PRODUCT DEVELOPMENT IN VETERINARY CARE, ADVANCES ORTHOPAEDIC APPLICATIONS
Source text for Eikon: ID:nBSEDCn96
Further company coverage: FRED.BO
(([email protected];))
Feb 12 (Reuters) - Fredun Pharmaceuticals Ltd FRED.BO:
SECURES ORDERS FROM SEA COUNTRIES
ORDERS WORTH 280 MILLION RUPEES
EXPANDS PRODUCT DEVELOPMENT IN VETERINARY CARE, ADVANCES ORTHOPAEDIC APPLICATIONS
Source text for Eikon: ID:nBSEDCn96
Further company coverage: FRED.BO
(([email protected];))
Fredun Pharmaceuticals Reappointed Daulat Nariman Medhora As Whole Time Director Designated As Joint Managing Director
Dec 21 (Reuters) - Fredun Pharmaceuticals Ltd FRED.BO:
DAULAT NARIMAN MEDHORA REAPPOINTED AS WHOLE TIME DIRECTOR DESIGNATED AS JOINT MANAGING DIRECTOR
Further company coverage: FRED.BO
(([email protected];))
Dec 21 (Reuters) - Fredun Pharmaceuticals Ltd FRED.BO:
DAULAT NARIMAN MEDHORA REAPPOINTED AS WHOLE TIME DIRECTOR DESIGNATED AS JOINT MANAGING DIRECTOR
Further company coverage: FRED.BO
(([email protected];))
Fredun Pharmaceuticals To Consider A Proposal For Fund Raising
Dec 8 (Reuters) - Fredun Pharmaceuticals Ltd FRED.BO:
TO CONSIDER A PROPOSAL FOR FUND RAISING
TO CONSIDER A PROPOSAL FOR FUND RAISING WORTH UPTO 1.2 BILLION RUPEES
Source text for Eikon: ID:nBSE8bp1rl
Further company coverage: FRED.BO
(([email protected];))
Dec 8 (Reuters) - Fredun Pharmaceuticals Ltd FRED.BO:
TO CONSIDER A PROPOSAL FOR FUND RAISING
TO CONSIDER A PROPOSAL FOR FUND RAISING WORTH UPTO 1.2 BILLION RUPEES
Source text for Eikon: ID:nBSE8bp1rl
Further company coverage: FRED.BO
(([email protected];))
Fredun Pharmaceuticals Re-Appoints Fredun Medhora As MD
Nov 8 (Reuters) - Fredun Pharmaceuticals Ltd FRED.BO:
RE-APPOINTS FREDUN MEDHORA AS MD
Source text for Eikon: ID:nBSE5KFFg9
Further company coverage: FRED.BO
(([email protected];))
Nov 8 (Reuters) - Fredun Pharmaceuticals Ltd FRED.BO:
RE-APPOINTS FREDUN MEDHORA AS MD
Source text for Eikon: ID:nBSE5KFFg9
Further company coverage: FRED.BO
(([email protected];))
India's Fredun Pharmaceuticals June-Quarter Net Profit Rises
July 19 (Reuters) - Fredun Pharmaceuticals Ltd FRED.BO:
JUNE-QUARTER NET PROFIT 24 MILLION RUPEES VERSUS PROFIT 9.4 MILLION RUPEES
JUNE-QUARTER INCOME FROM OPERATIONS 612.3 MILLION RUPEES VERSUS 481.3 MILLION RUPEES
Source text for Eikon: ID:nBSE1BDGBw
Further company coverage: FRED.BO
(([email protected];))
July 19 (Reuters) - Fredun Pharmaceuticals Ltd FRED.BO:
JUNE-QUARTER NET PROFIT 24 MILLION RUPEES VERSUS PROFIT 9.4 MILLION RUPEES
JUNE-QUARTER INCOME FROM OPERATIONS 612.3 MILLION RUPEES VERSUS 481.3 MILLION RUPEES
Source text for Eikon: ID:nBSE1BDGBw
Further company coverage: FRED.BO
(([email protected];))
India's Fredun Pharmaceuticals March-Quarter Profit Rises
May 25 (Reuters) - Fredun Pharmaceuticals Ltd FRED.BO:
MARCH-QUARTER PROFIT 38.9 MILLION RUPEES VERSUS 23 MILLION RUPEES YEAR AGO
MARCH-QUARTER TOTAL INCOME FROM OPERATIONS 798 MILLION RUPEES VERSUS 718.5 MILLION RUPEES YEAR AGO
Source text for Eikon: ID:nBSEb7lWKb
Further company coverage: FRED.BO
(([email protected];))
May 25 (Reuters) - Fredun Pharmaceuticals Ltd FRED.BO:
MARCH-QUARTER PROFIT 38.9 MILLION RUPEES VERSUS 23 MILLION RUPEES YEAR AGO
MARCH-QUARTER TOTAL INCOME FROM OPERATIONS 798 MILLION RUPEES VERSUS 718.5 MILLION RUPEES YEAR AGO
Source text for Eikon: ID:nBSEb7lWKb
Further company coverage: FRED.BO
(([email protected];))
Events:
Dividend
Dividend
Dividend
Dividend
Dividend
Dividend
Dividend
More Micro Cap Ideas
See similar 'Micro' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
-
Business
-
Financials
-
Share Price
-
Shareholdings
What does Fredun Pharma do?
Fredun Pharmaceuticals Limited is a trusted manufacturer of pharmaceutical products, dietary supplements, nutraceuticals, and healthcare products in Africa, Southeast Asia, CIS countries, and Latin America, aiming to be a holistic healthcare provider.
Who are the competitors of Fredun Pharma?
Fredun Pharma major competitors are Gennex Lab, Trident Lifeline, Ambalal Sarabhai Ent, Balaxi Pharma., Coral Laboratories, Lyka Labs, Brooks Laboratories. Market Cap of Fredun Pharma is ₹322 Crs. While the median market cap of its peers are ₹315 Crs.
Is Fredun Pharma financially stable compared to its competitors?
Fredun Pharma seems to be less financially stable compared to its competitors. Altman Z score of Fredun Pharma is 3.41 and is ranked 7 out of its 8 competitors.
Does Fredun Pharma pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Fredun Pharma latest dividend payout ratio is 2.11% and 3yr average dividend payout ratio is 3.31%
How has Fredun Pharma allocated its funds?
Companies resources are allocated to majorly unproductive assets like Inventory, Accounts Receivable
How strong is Fredun Pharma balance sheet?
Balance sheet of Fredun Pharma is strong. But short term working capital might become an issue for this company.
Is the profitablity of Fredun Pharma improving?
Yes, profit is increasing. The profit of Fredun Pharma is ₹18.8 Crs for TTM, ₹15.62 Crs for Mar 2024 and ₹10.81 Crs for Mar 2023.
Is the debt of Fredun Pharma increasing or decreasing?
Yes, The debt of Fredun Pharma is increasing. Latest debt of Fredun Pharma is ₹137 Crs as of Sep-24. This is greater than Mar-24 when it was ₹103 Crs.
Is Fredun Pharma stock expensive?
Fredun Pharma is not expensive. Latest PE of Fredun Pharma is 17.12, while 3 year average PE is 51.34. Also latest EV/EBITDA of Fredun Pharma is 9.39 while 3yr average is 19.24.
Has the share price of Fredun Pharma grown faster than its competition?
Fredun Pharma has given lower returns compared to its competitors. Fredun Pharma has grown at ~-11.52% over the last 2yrs while peers have grown at a median rate of 35.29%
Is the promoter bullish about Fredun Pharma?
Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in Fredun Pharma is 48.93% and last quarter promoter holding is 48.93%.
Are mutual funds buying/selling Fredun Pharma?
There is Insufficient data to gauge this.